申请人:Fukumoto Shoji
公开号:US20140024650A1
公开(公告)日:2014-01-23
Provided is a compound having an AMPA receptor function enhancing action, and useful as a prophylactic or therapeutic drug for depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like. A compound represented by the formula (I):
wherein each symbol is as defined in the present specification,
or a salt thereof.
提供了一种具有AMPA受体功能增强作用的化合物,可用作预防或治疗抑郁症、阿尔茨海默病、精神分裂症、注意力缺陷多动障碍(ADHD)等药物。该化合物由式(I)表示:其中每个符号如本说明书所定义,或其盐。